AMWL
American Well Corporation4.7000
+0.0000+0%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
FY Q3 '25
Florida win, divestiture details surface
Q&A spotlighted a competitive Florida Blue win, deinstalling a major rival due to vendor fatigue and fragmentation—echoing prepared remarks but adding win specifics. Management clarified divestitures target non-core assets like hospital automation, redirecting resources without altering guidance or 2026 cash flow breakeven timeline. AI monetizes indirectly via partner rev share (Sword, HelloHeart) and platform traction, not extra fees; margins stay software-mix driven. Retention ranks first for breakeven. Macro hits non-core harder, core resilient. Retention is priority number one. Investors eye divestiture execution.
Key Stats
Market Cap
76.94MP/E (TTM)
-Basic EPS (TTM)
-7.19Dividend Yield
0%Recent Filings
8-K
10-Q
Q3 FY2025 results
American Well's Q3 revenue dipped 8% year-over-year to $56.3M, yet platform subscriptions climbed 18% to $30.9M, signaling steady core growth amid a 23% drop in visits to $21.2M after divesting the non-core APC business in January for $20.4M upfront cash, booking an $8.7M YTD gain. Operating loss narrowed sharply 38% to $29.3M, with costs down 21% thanks to 29% headcount cuts and lower provider expenses, while diluted EPS improved to -$2.00 from -$2.87. Cash burn eased to $48.6M YTD operating outflow versus $113.9M last year, leaving $200.9M in cash and no debt. The APC sale sharpens focus on Converge platform profitability. Still, reliance on two clients for 53% of revenue poses concentration risks.
8-K
Amwell Q3 beats guidance
Amwell reported Q3 2025 revenue of $56.3 million, beating prior guidance with subscription revenue at $30.9 million and AMG visits generating $21.2 million, yet net loss widened to $31.9 million amid higher costs. Gross margin hit 52.4%, while Adjusted EBITDA came in at ($12.7) million. The company narrowed full-year revenue outlook to $245-248 million and targets positive cash flow in 2026. Losses persist, but execution sharpens.
10-Q
Q2 FY2025 results
American Well posted Q2 revenue of $70.9M, up 13% y/y from $62.8M, fueled by $12.9M more in platform subscriptions from strategic clients, though visits dipped to $22.8M after the APC divestiture offset primary care gains. Gross margins improved sharply as costs fell 21% y/y to $31.1M, thanks to 22% headcount cuts and provider efficiencies, narrowing the operating loss to $20.4M from $52.4M. Diluted EPS of -$1.24 beat last year's -$3.36 on 15.9M shares, with no anti-dilution flagged. Cash burn eased to $29.8M YTD operating outflow, bolstered by $20.4M divestiture proceeds, leaving $219.1M in cash and no debt. The January 2025 APC sale for $20.7M upfront cash recognized $10.7M gain and shed $3.7M intangibles. Non-GAAP adjusted EBITDA not disclosed in the 10-Q. Yet competition from new digital health players lingers.
8-K
Amwell Q2 revenue rises
Amwell reported Q2 2025 revenue of $70.9 million, up from $62.8 million a year ago, with subscription revenue at $40.4 million and 1.2 million total visits. Gross margin hit 56.1%, while net loss narrowed to $19.5 million from $50.6 million; adjusted EBITDA improved to ($4.7) million from ($35.0) million. Strategic wins included adding Florida Blue and extending the US Defense Health Agency contract, validating platform value amid cost alignments. Revenue quality advances. Yet risks loom from telehealth volatility.
IPO
Website
Employees
Sector
Industry
CCLD
CareCloud, Inc.
3.21+0.02
CRVW
Careview Communications, Inc.
0.02+0.00
HWAIF
HealWELL AI Inc.
0.64+0.00
OMDA
Omada Health, Inc.
14.61+0.02
OWLT
Owlet, Inc.
12.72-0.19
TDOC
Teladoc Health, Inc.
7.41+0.07
WEAV
Weave Communications, Inc.
6.98+0.23
WHTCF
Well Health Technologies Corp.
2.89+0.03
WLSS
WELSIS CORP.
2.40+0.00
WORX
SCWorx Corp.
0.21-0.01